5-heptadecylresorcinol has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Y; Li, Q; Liu, J; Wang, J; Wang, Z; Yang, Z | 1 |
1 other study(ies) available for 5-heptadecylresorcinol and Atherogenesis
| Article | Year |
|---|---|
5-Heptadecylresorcinol Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice by Modulating SIRT3 Signaling: The Possible Beneficial Effects of Whole Grain Consumption.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Resorcinols; Signal Transduction; Sirtuin 3; Whole Grains | 2022 |